Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 07:47 ET | Source: Research and Markets

Genetic Testing Market Research Report 2025-2030: Advances in Genomics, Aging Populations, Pharmacogenomics, Oncology Liquid Biopsies, Fertility Testing, and Rising DTC Adoption Driving Growth

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Genetic Testing Markets 12th Edition: Global Market Analysis with Forecasts by Applications, Technologies, Products and Users. With Executive and...
October 31, 2025 09:05 ET | Source: Myriad Genetics, Inc.

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

SALT LAKE CITY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the...
October 03, 2025 11:52 ET | Source: Research and Markets

Tech Advancements and Regional Market Strategies Shaping Pharmacogenomics, 2025-2033

Dublin, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Market Report by Technology, Application, End User, and Region 2025-2033" has been added to ResearchAndMarkets.com's offering. The...
September 08, 2025 06:58 ET | Source: Research and Markets

Personalized Medicine (Biologics, Small Molecules, Gene Therapies) Market Growth Analysis Report 2025-2033 | AI, Targeted Oncology Therapies, and Biomarker Adoption Fueling Innovations

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "Personalized Medicine: Market Share, and Growth Analysis by Product Type (Biologics, Small Molecules, Gene Therapies), Application, End User,...
September 03, 2025 16:30 ET | Source: Myriad Genetics, Inc.

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new...
August 12, 2025 05:32 ET | Source: Research and Markets

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "United States Personalized Medicine Market - Genomic Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's...
July 17, 2025 10:01 ET | Source: Research and Markets

Whole Genome Sequencing Market: Projected Growth through 2030 with Regional Insights

Dublin, July 17, 2025 (GLOBE NEWSWIRE) -- The "Whole Genome Sequencing: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for whole genome sequencing...
June 12, 2025 04:07 ET | Source: Research and Markets

Genetic Testing Market Research 2025: Genetic Discoveries Creating New Diagnostic Markets

Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides"...
June 12, 2025 04:05 ET | Source: Research and Markets

Whole Genome and Exome Sequencing Market Research 2025 with Executive and Consultant Guides

Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Market: By Application, Organism and Product with Executive and Consultant Guides" has been added to ...
June 10, 2025 04:14 ET | Source: Research and Markets

Human Gene Sequencing Markets, Strategies, Trends and Forecasts Report 2025: New Diagnoses, Wellness and Prevention, Fertility Technology, Cancer Screening, Management and Monitoring Fueling Growth

Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Human Gene Sequencing Markets, Strategies & Trends: Forecasts By Application, By Technology, By Workflow, By Product, and By Country with Executive...